- Biolyse Pharma offers to supply enzalutamide (Xtandi) for $3 per pill to Medicare and developing countries
- KEI comment on USTR's 2016 Special 301 report
- Transparency of patents on medicines and other technologies
- 2015 Oct 16 version: RCEP draft text for investment chapter
- Letter to HHS and NIH regarding impact of high prices on cost effectiveness of Xtandi
- 2015 Oct 15 version: RCEP IP Chapter
- Global pharmaceutical sales, by region, 2013-2015
- KEI comment on WIPO report on patents landscape for the WHO essential medicines list
- Obama Administration memo: "Background on TPP Biopharma Provisions" describes how TPP will raise drug prices
- CDIP 17: Asia Pacific and African Group raise concerns re: WIPO's position on the UN High-Level Panel on Access to Medicines
Federal Appellate Court: Pay-for-Delay is "prima facie evidence of an unreasonable restraint of trade.”Submitted by Krista Cox on 19. July 2012 - 7:33
On Monday, July 16, 2012, the Court of Appeals for the Third Circuit ruled that pay-for-delay agreements between branded pharmaceutical companies and generic manufacturers are prima facie evidence of anticompetitive behavior.
BRCA gene case: James D. Watson, co-founder of double helix structure, rejects patentability of DNA and other amici filingsSubmitted by Krista Cox on 16. July 2012 - 10:23
On Friday, July 20, 2012, the Court of Appeals for the Federal Circuit will re-hear the case Association for Molecular Pathology, et. al. v. United States Patent and Trademark Office, et. al. This case, involving the patent eligibility of DNA--specifically claims directed at two human genes, BRCA1 and BRCA2, associated with an individual's susceptibility to breast cancer--has been litigated for three years now and has resulted in fractured rulings and widely varying reasoning.
Egypt questions EU on the applicability of the three-step test to Article 10.2 of the Berne ConventionSubmitted by thiru on 16. July 2012 - 8:49
The first day of the 24th session of the World Intellectual Property Organization (WIPO) Standing Committee on Copyright and Related Rights (SCCR) has gone into full swing with a textual proposal tabled by Ecuador, Peru and Uruguay on limitations and exceptions for educational and research institutions, and a textual proposal submitted by Brazil on L&Es for educational and research institutions.
The live stream audio capture of these proceedings can be found here: http://www.streamtext.net/player?Event=WIPO
The World Intellectual Property Organization (WIPO) has convened the 24th Standing Committee on Copyright and Related Rights (SCCR) which will take place from 16 July 2012 to 25 July 2012 at its headquarters in Geneva, Switzerland. Ambassador Darlington Mwape (Zambia) is chairing the 24th SCCR. The morning session of the SCCR witnessed opening remarks by group coordinators. The following statement was delivered by Egypt on behalf of the African Group.
African Group Opening Statement
WIPO SCCR 24
Posner's dismissals of the patent infringement suits in Apple versus Motorola cites eBay and compulsory licensingSubmitted by thiru on 14. July 2012 - 10:15
On 22 June 2012, Judge Richard Posner, dismissed with prejudice the patent infringement suits filed in Apple Inc. and NEXT Software, Inc. v Motorola, Inc. and Motorola Mobility, Inc. in the United States District Court for the Northern District of Illinois (Eastern Division). In this case, the judge cited the eBay decision noting that neither party was entitled to injunctive relief as neither party demonstrated that "damages would not be an adequate remedy".
The 13th round of negotiations for the Trans-Pacific Partnership Agreement (TPPA) took place in San Diego, CA, USA from 2-10 July 2012.
Notes on Intellectual Property
In a May 9, 2012 hearing in the Senate Judiciary Committee on oversight of the intellectual property enforcement coordinator, Senator Leahy asked Victoria Espinel about patent trolls, and failures to license patents on reasonable terms to achieve interoperability where standards are important. Leahy asked Victoria Espinel to work with USDOJ's antitrust officials to deal with abuses by patent holders in both cases.
WIPO text-based negotiations on an instrument to protect traditional cultural expressions (9 July 2012-13 July 2012)Submitted by thiru on 6. July 2012 - 4:43
The World Intellectual Property Organization (WIPO) is convening the 22nd session of the Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore from 9 July 2012-13 July 2012. The 22nd session will deliberate over draft articles relating to the protection of traditional cultural expressions contained in document (WIPO/GRTKF/IC/22/4). These discussions are guided by the mandate of the Fortieth Session of the WIPO General Assembly which states:
The vote to reject a delay of the final ACTA vote was 420 Vs 255, followed by the rejection of ACTA by a vote of 478 to 39.
KEI Director James Love statement:
Deputy USPTO Director Teresa Stanek Rea has issued a retraction of her statement regarding Administration support for 12 years of exclusive rights in test data for biologic drugs, and moderated somewhat her statement on the India compulsory license for Nexavar. USTR also issued a statement on the issue of biologic test data in response to Rea's earlier comments.
[update: See: Leak of TPP text on copyright Limitations and Exceptions]
On June 27, 2012, Teresa Stanek Rea, the Deputy Under Secretary of Commerce for Intellectual Property and the Deputy Director of the United States Patent and Trademark Office (USPTO), testified at a hearing on: "International IP Enforcement: Protecting Patents, Trade Secrets and Market Access", before the US House of Representatives, Judicary Committee, Subcommittee on Intellectual Property, Competition, and the
Earlier this month, the European Parliament and the European Commission released a new compromise text on orphan works.
The Compromise Text is available here:
KEI sees the text as a step backwards for access to knowledge. The proposed directive makes far too many compromises, is too limited in terms of the beneficiaries and uses of works, and creates complicated, burdensome and costly procedures and record keeping requirements.